Chimeric antigen receptor compositions
    8.
    发明授权
    Chimeric antigen receptor compositions 有权
    嵌合抗原受体组合物

    公开(公告)号:US09574014B2

    公开(公告)日:2017-02-21

    申请号:US15156159

    申请日:2016-05-16

    申请人: City of Hope

    摘要: Provided herein are compositions which exhibit novel diagnostic capabilities and allow to rapidly add functionality to adoptive immunotherapy. The compositions include isolated nucleic acids encoding proteins including antibody regions capable of binding compounds including a peptidyl moiety (e.g., a meditope). The recombinant proteins provided herein are useful, inter alia, for a broad variety of therapeutic and diagnostic purposes. For example, the recombinant proteins provided herein including embodiments thereof may be used as non-invasive means to characterize chimeric antigen receptor (CAR) T cells before and/or during treatment of diseases (e.g., cancer).

    摘要翻译: 本文提供了表现出新的诊断能力并允许快速添加过继性免疫治疗功能的组合物。 组合物包括编码蛋白质的分离的核酸,包括能够结合化合物的抗体区域,所述化合物包括肽基部分(例如,中间体)。 本文提供的重组蛋白尤其可用于多种治疗和诊断目的。 例如,本文提供的重组蛋白质包括其实施方案可以用作在疾病(例如癌症)治疗之前和/或期间表征嵌合抗原受体(CAR)T细胞的非侵入性手段。